Medical oncologist Dr. Andrew Hsu explains how hypokalaemia treatment works and how to treat it.
Read moreMedical oncologists Dr. Jodi Bussmann and Dr. David A. Karp describe the different types of hypokalamias.
Hsu is a resident on the faculty of the University of Pittsburgh School of Medicine and director of the Center for Patient Safety and Quality of Care at the University Hospitals Case Western Reserve University.
He also is director of clinical studies for the Center on Hematology and Blood Disorders at the Cleveland Clinic.
In the episode, Hsu describes how he and colleagues from the Cleveland Center for the Study of Hematopoietic Oncology developed a new way to treat patients with the disease.
In this case, they found a way to stop the blood from clotting in a patient’s blood vessels.
Hsus is also an associate professor at the Ohio State University College of Medicine.
He is an expert on the treatment of chronic myeloid leukemia (CML).
In addition, he is a physician-in-residence at the Case Western Residency Program at the Mayo Clinic in Rochester, Minn.
Hsu is also the editor-in chief of the Journal of Hemato-Oncology.
The Cleveland Clinic hosts the Case-Western Reserve Health Care System.
Its main hospital is Cleveland Clinic Medical Center.
It has more than 600 physicians and 1,400 residents, with more than 2,000 patients per year.
Its primary care physician is Chief of the Hematologic Department at the hospital, and its other doctors and nurses are all on the Cleveland staff.
The Cleveland Clinic also has four research hospitals in Cleveland, Columbus, St. Louis and Grand Rapids.
For more information, visit CaseWestern.com/CuyahogaHealth.
Read or Share this story: http://cin.ci/1lk5yqr